Intrinsic Value of S&P & Nasdaq Contact Us

Metsera, Inc. MTSR NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
39/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Metsera, Inc. (MTSR) reported total assets of $567.64M and total liabilities of $230.45M for quarter ending 2025-09-30, resulting in total equity of $337.19M.

The company held $448.46M in cash and short-term investments. Total debt stood at $2.84M, with net debt of $-445.62M. The Debt-to-Equity (D/E) ratio was 0.01 (conservative).

Current ratio is 4.25, indicating strong short-term liquidity. Interest coverage is -15260.4x (weak).

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (40/100) — Total assets $567.64M and equity $337.19M support the company's competitive scale

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
FUTURE
75/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
40/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
N/A
No coverage
Metsera, Inc. Balance Sheet History
Metric Q3 FY2025 Q2 FY2025 Q1 FY2025 Q4 FY2024
Total Assets $567.64M$639.66M$690.7M$450.99M
Total Liabilities $230.45M$190.43M$185.31M$163.64M
Total Debt $2.84M$1.06M$9.73M$9.8M
Cash & Investments $448.46M$530.92M$588.34M$352.45M
Total Stockholders Equity $337.19M$449.23M$505.39M$287.35M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message